Thomas was recognized in both the Most Innovative Woman of the Year – Healthcare and Female Executive of the Year Susan Thomas, Chief Commercial Officer...
Transformative alliance to Create the world-leading clinical infrastructure and breakthrough biotechnology to redefine the therapeutic landscape of sepsis. ABIONYX Pharma, (FR0012616852 – ABNX), a next-generation...
Exstent, a UK-based medical device company, developing personalised external aortic support to preserve the native aorta, today announced the appointment of Matt Thompson as Chief...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, will attend theJefferies Global Healthcare ConferenceinLondon from 17 to 20 November 2025. The AdvanCell team...
The brand refresh includes a newly designed shared logo for ENTA and Hümi, symbolizing the strong connection and unified purpose between the two entities. ENT...
Onward Therapeutics today announced the completion of a share exchange, under which Onward Therapeutics, Inc. (Onward Taiwan) has become the group’s global holding and headquarters,...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of...
Investment by Avego will extend reach, accelerate AI innovation, and deepen industry partnerships. myTomorrows, a health technology company that connects patients with all possible pre-approval...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide the radiology module of its enterprise imaging solution to Xcare Group, a health network in...
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide New...
Edwards Lifesciences (NYSE: EW) today announced its founding sponsorship of the American Heart Association’s Heart Valve Initiative, a national effort to improve care and outcomes...
Highlights from the Data Presentation Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at AASLD’s The Liver Meeting®, in...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has completed its...
– The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomide – – In a...
One Equity Partners (“OEP”), a middle market private equity firm, today announced it has exited its investment in InfuCare Rx, Inc. (“InfuCare” or the “Company”) through a...